RE:RE:RE:RE:RE:RE:RE:RE:I posted this in Washngton Post comments section Madheights wrote: Interesting take. But you may be correct. Ultimately I'm hoping that however this shakes out, that no investor(s) with deep pockets would shell out cash unless they had "confidence" in what they are investing. Common sense. Therefore, with that "confidence", the deal may not be as discounted as we pessimistically might think.
Although not in the past of management style or what have you, I'd like to hear an announcement that all shareholders of a certain date of record will be granted the ability to buy additional shares at such and such price with perhaps warrants, options, etc sweetening the deal.
This, I think, is a win-win. I think the current market apprehension is all about existing shareholders feeling like they are somewhat hostage to a situation beyond their control. So why not give an element of control?
What so you think?
Including the retail investor is great but we've had all the opportunity in the world to buy these discounted shares already. I'd prefer they release a great series of NR's with preclinical data on brain cancer, reporting on first three with cystoscopy and the beginning of the next 6 patients at a higher dose. Let's see that - if they have it. Then existing warrants will be purchased and the price of financing could be much much higher with 1/2 warrants that are double the price of PP share. That's what I want to see.